Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$7,540,817
+$1,885,152 QoQ
Shares Held
6,287
+2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,422
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL ADVISORS INC/OK holds $173,896,300 across 10 Drug Manufacturers - General names. LLY ranks #3 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
447,129 | $112,515,541 | |
| 2 | PFE |
Pfizer Inc
|
1,770,761 | $42,639,924 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
6,287 | $7,540,817 | |
| 4 | JNJ |
Johnson & Johnson
|
22,507 | $5,716,102 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,641 | $1,419,814 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,821 | $1,261,998 | |
| 7 | NVO |
Novo Nordisk A S
|
25,516 | $1,223,237 | |
| 8 | AMGN |
Amgen Inc
|
2,255 | $816,580 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,540,817 | 6,287 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,655,665 | 6,149 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,687,734 | 6,223 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,444,475 | 5,825 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $5,259,488 | 6,747 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,218,099 | 6,318 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,188,872 | 5,426 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,038,340 | 5,687 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $4,115,857 | 4,546 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,437,805 | 4,419 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,304,282 | 3,953 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,818,722 | 3,386 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,537,316 | 3,278 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $984,241 | 2,866 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,021,791 | 2,793 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $881,775 | 2,727 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $890,659 | 2,747 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $780,930 | 2,727 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $730,878 | 2,646 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $634,925 | 2,748 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $676,395 | 2,947 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $479,753 | 2,568 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $453,335 | 2,685 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $219,809 | 1,485 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $230,344 | 1,403 | Shares | Sole | 2020-09-02 | |
| No filing history on record for this holder in this stock. | ||||||